The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Oct. 28, 2025

Filed:

May. 01, 2024
Applicant:

Helix, Inc., San Mateo, CA (US);

Inventors:

Alexandre Bolze, San Francisco, CA (US);

Joseph J. Grzymski, San Mateo, CA (US);

Assignee:

Helix, Inc., San Mateo, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16H 50/30 (2018.01); G16B 30/00 (2019.01); G16B 40/00 (2019.01); G16H 10/60 (2018.01);
U.S. Cl.
CPC ...
G16H 50/30 (2018.01); G16B 30/00 (2019.02); G16B 40/00 (2019.02); G16H 10/60 (2018.01);
Abstract

Various embodiments disclosed relate to a method of preventive care for breast cancer. A method may include analyzing sequenced genetic data originating from the patient to determine whether the patient has a qualifying variant in any of genes BRCA1, BRCA2, PALB2, ATM, and CHEK2, wherein the qualifying variant can include one or more pathogenic variants, variants of uncertain significance (VUS), or combinations thereof. In an event that the patient does not have a qualifying variant in any of genes BRCA1, BRCA2, PALB2, ATM, and CHEK2, the method can include calculating a polygenic risk score (PRS) of the patient. If the patient has a PRS lower than a predetermined threshold, the method can include classifying the patient as low risk for breast cancer.


Find Patent Forward Citations

Loading…